Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of a low and high dose of a budesonide
effervescent tablet and oral viscous budesonide suspension vs. placebo for the induction
treatment of active eosinophilic esophagitis.